portrait of Keri Donaldson

Keri Donaldson, MD, MSCE

Chief Executive Officer

Keri has dedicated his medical career to improving people’s lives through advancements in pathology, genomics, and diagnostics. His experience in the U.S. health system made him realize that to create real change, entirely new solutions were needed. Prior to founding SOLVD Health, he directed numerous clinical laboratories and held key positions within respected institutions including University of Pennsylvania, Penn State Health, and Temple University. In addition, he is active in numerous national committees and professional societies focused on improving diagnostic testing and patient care. He has an MD from Temple University School of Medicine and a Master of Science in Clinical Epidemiology (MSCE) from the University of Pennsylvania School of Medicine.
Thomas Kuehn, Ph.D.

Thomas J. Kuehn, Ph.D.

Executive Vice President and
Chief R&D Officer

Dr. Kuehn is a visionary entrepreneur and inventor with 30-year career devoted to multidisciplinary science, R&D, and systems engineering management including experience in manufacturing, marketing, sales and service of advanced analytical instrumentation, biotechnology, bioinformatics, and information technology enterprises He co-founded and led several high-tech companies since 1982 including Viking Instruments, Ion Metrics, Biospherex, and Metabiomics. As co-founder of Viking Instruments he co-invented, designed, and manufactured portable GC/MS analytical instrumentation and later co-invented a portable IMS/MS at Ion Metrics. He has served as a Board member and investor in several start-up firms and consultant to Fortune 100 defense and information technology companies in R&D, systems integration, and business development roles.
Greg Kuehn

Gregory J. Kuehn, MBA

Vice President and
Chief Operating Officer

Gregory J. Kuehn, MBA, President and COO, is a co-founder with an MBA from the University of Colorado with BS from the College of William and Mary in molecular biology and computer science. He was a business consultant (2006-2010) at Flashback Technologies and VetDC in Colorado, with experience in MDx Product Development, regulatory affairs, business and corporate development, strategic partnerships, contracting, marketing, sales, advertising, financial modeling, project management, and web design. Mr. Kuehn has built and managed multi-disciplinary teams to achieve the company’s goal of commercializing a breakthrough colon cancer screening test.
Louis Korman, MD

Louis Y. Korman, MD

Advisory Board Member

Dr. Korman completed his medical school education at the State University of New York in Syracuse, graduating Cum Laude and being elected to the Alpha Omega Alpha Medical Honor Society. He moved to Washington, DC in 1978 to continue his training in Gastrointestinal Diseases at the National Institutes of Health Digestive Disease branch with an interest in the regulation of gastrointestinal function. Dr. Korman is a leading practitioner and expert in the diagnosis and treatment of patients with diseases of the gastrointestinal tract and liver and has extensive experience in basic and applied clinical research and the application of information technology to clinical practice. Dr. Korman is an attending physician in Chevy Chase Clinical Research and Capital Digestive Care, one of largest single specialty GI practice groups in the US with over fifty-five gastroenterologists. In addition to his clinical practice, he teaches gastroenterology and endoscopy in the Gastroenterology Training Program at the Veterans Administration Hospital/Georgetown University Fellowship program. Dr. Korman is a principal investigator for both NIH and industry sponsored clinical trials in gastrointestinal diseases.
Patrick Gillevet, Ph.D.

Patrick M. Gillevet, Ph.D.

Advisory Board Member

Dr. Patrick Gillevet, Chairman of the life science advisory board, is a pioneering molecular ecologist, co-founder, and primary inventor of Metabiomics patented MultiTag™ Sequencing and other gateway technology. He brings extensive experience in development of technology and methodology in the fields of genomics and bioinformatics. He was the technical director of the Center of Prokaryotic Genome Analysis at the University of Illinois, the Director of the Harvard University Genome Laboratory from 1990-­1993, and currently heads the Microbiome Analysis Center at George Mason University in Manassas, VA.

Contact Us

If you are interested in learning more about how Metabiomics is working to change the colon cancer screening paradigm, we would love to hear from you.

12 + 12 =